Industry:
BioPharma AI
Headquarters:
Newcastle Upon Tyne,Newcastle upon Tyne,United Kingdom,Europe
Technology:
Biomarker Discovery & Validation
Investor Type:
Private Equity Funds
Funding Status:
private
